Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FYBR
2076
CALL
DELISTED
Frontier Communications
FYBR
| $15.9M | ﹤0.01% |
1,018,000
-383,700
| -27% | -$6.23M |
|
2077
Corpay
CPAY
$27.4B
| $15.9M | ﹤0.01% |
+62,377
| New | +$16.3M |
|
2078
PUT
Travelers Companies
TRV
$77.2B
| $15.9M | ﹤0.01% |
97,400
+34,900
| +56% | +$5.83M |
|
2079
Veracyte
VCYT
$3.32B
| $15.9M | ﹤0.01% |
711,381
+503,449
| +242% | +$12.9M |
|
2080
Immuneering
IMRX
$327M
| $15.9M | ﹤0.01% |
2,066,371
-5,197
| -0.3% | -$47.8K |
|
2081
CALL
Ralph Lauren
RL
$23.2B
| $15.9M | ﹤0.01% |
136,600
+21,400
| +19% | +$2.59M |
|
2082
Edgewise Therapeutics
EWTX
$4.8B
| $15.9M | ﹤0.01% |
2,767,436
+92,446
| +3% | +$628K |
|
2083
Churchill Downs
CHDN
$6.33B
| $15.8M | ﹤0.01% |
136,463
+104,089
| +322% | +$12.9M |
|
2084
Amdocs
DOX
$6.18B
| $15.8M | ﹤0.01% |
187,408
+151,317
| +419% | +$13.7M |
|
2085
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $15.8M | ﹤0.01% |
403,800
+159,800
| +65% | +$6.52M |
|
2086
CALL
Alerian MLP ETF
AMLP
$13.2B
| $15.8M | ﹤0.01% |
374,600
+95,200
| +34% | +$3.91M |
|
2087
PUT
Global X Uranium ETF
URA
$6.27B
| $15.8M | ﹤0.01% |
584,600
+221,400
| +61% | +$5.2M |
|
2088
Rivian
RIVN
$22.2B
| $15.8M | ﹤0.01% |
651,034
-5,870,407
| -90% | -$137M |
|
2089
Acrivon Therapeutics
ACRV
$83.5M
| $15.8M | ﹤0.01% |
1,650,457
+811
| +0% | +$9.37K |
|
2090
Enbridge
ENB
$111B
| $15.8M | ﹤0.01% |
475,321
+290,413
| +157% | +$10.3M |
|
|
ELME
2091
Elme Communities
ELME
$144M
| $15.8M | ﹤0.01% |
1,155,291
+425,258
| +58% | +$6.58M |
|
2092
CALL
XP
XP
$8.17B
| $15.8M | ﹤0.01% |
683,414
-2,014,600
| -75% | -$50.5M |
|
2093
PUT
Steel Dynamics
STLD
$36.7B
| $15.7M | ﹤0.01% |
146,800
-34,600
| -19% | -$3.6M |
|
2094
PUT
Abercrombie & Fitch
ANF
$4.8B
| $15.7M | ﹤0.01% |
279,000
+51,200
| +22% | +$2.27M |
|
2095
Extreme Networks
EXTR
$3.2B
| $15.7M | ﹤0.01% |
647,870
+428,706
| +196% | +$11.6M |
|
2096
Microchip Technology
MCHP
$43B
| $15.6M | ﹤0.01% |
200,207
+132,495
| +196% | +$11.1M |
|
|
DQ
2097
Daqo New Energy
DQ
$991M
| $15.6M | ﹤0.01% |
515,386
+174,205
| +51% | +$6.21M |
|
2098
Lucid Motors
LCID
$2.45B
| $15.6M | ﹤0.01% |
279,065
+264,479
| +1,813% | +$17.1M |
|
2099
PUT
iShares Russell 1000 Growth ETF
IWF
$128B
| $15.6M | ﹤0.01% |
234,400
+149,600
| +176% | +$10.3M |
|
|
NOVA
2100
CALL
DELISTED
Sunnova Energy
NOVA
| $15.5M | ﹤0.01% |
1,481,900
-15,000
| -1% | -$234K |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,407 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.